Autres langues Abion Inc.

Actions

A203400

KR7203400007

Recherche biotechnologique et médicale

Cours en clôture Korea S.E. 14/08/2026			Varia. 5j.	Varia. 1 janv.
676,00 ^KRW	-2,03%		-.--%	-78,40%

07/04	ABION dévoile des données précliniques montrant que l'anticorps de fusion IFN-ß ABN202 surpasse les ADC ciblant TROP2	CI
04/04/25	Abion va céder 5,9 milliards de wons d'actions de Vivozon Inc.	RE

Autres langues

07/04	ABION Announces Preclinical Data Showing IFN-? Antibody Fusion Abn202 Outperforms Trop2-Targeting ADCs
04/04/25	Abion To Divest 5.9 Billion Won Worth Of Shares In Vivozon Inc
30/12/24	Nuon Co., Ltd. completed the acquisition of 4.06% stake in ABION Inc. from KPM TECH Co., Ltd..
26/12/24	KPM TECH Co., Ltd. announced that it has received KRW 5.999999711 billion in funding from ABION Inc.
23/12/24	Nuon Co., Ltd. agreed to acquire 4.06% stake in ABION Inc. from KPM TECH Co., Ltd. for KRW 8 billion.
23/12/24	ABION Inc. announced that it has received KRW 8.0011152 billion in funding from TELCON RF PHARMACEUTICAL. Inc.
18/12/24	KPM TECH Co., Ltd. announced that it expects to receive KRW 5.999999711 billion in funding from ABION Inc.
05/12/24	ABION Inc. completed the acquisition of 7.56% stake in Vivozon, Inc. from TELCON RF PHARMACEUTICAL. Inc..
05/12/24	ABION Inc. announced that it has received KRW 20.019993378 billion in funding from TELCON RF PHARMACEUTICAL. Inc.
11/11/24	ABION Inc. announced that it expects to receive KRW 20.019993378 billion in funding from TELCON RF PHARMACEUTICAL. Inc.
11/11/24	ABION Inc. agreed to acquire 7.56% stake in Vivozon, Inc. from TELCON RF PHARMACEUTICAL. Inc. for KRW 20.1 billion.
28/10/24	ABION Inc. announced that it expects to receive KRW 9.999995616 billion in funding from TELCON RF PHARMACEUTICAL. Inc.
28/12/23	Abion Inc. announced that it has received KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc.
27/12/23	TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 6 billion in funding from Abion Inc.
27/12/23	Gencurix Inc. announced that it has received KRW 2 billion in funding from Abion Inc.
26/12/23	TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 6 billion in funding from Abion Inc.
26/12/23	Gencurix Inc. announced that it expects to receive KRW 2 billion in funding from Abion Inc.
26/12/23	Abion Inc. announced that it has received KRW 8.499991272 billion in funding
18/12/23	Abion Inc. announced that it expects to receive KRW 8.499991272 billion in funding
13/10/23	ABION Presents New Efficacy Data for ABN401
11/04/23	Abion Inc. announced that it expects to receive KRW 21 billion in funding from LabGenomics Co., Ltd., Atinum Investment Co., Ltd, NH Investment & Securities Co., Ltd., Investment and others
21/03/23	Abion Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
21/03/23	Abion Inc. Auditor Raises 'Going Concern' Doubt
06/11/20	Abion Inc. announced that it has received KRW 5.8 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm
29/10/20	Abion Inc. announced that it expects to receive KRW 5.8 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm and other investors